Answers are grounded in this paper and cite their sources.
Clinical evaluations correlate inflammation response with treatment outcomes in rheumatoid arthritis, suggesting biomarkers may improve patient care.
2C-DAS28 response correlates significantly with ultrasound-detected synovitis and is associated with improved clinical outcomes. This may support identification of biomarkers of treatment efficacy and clinical stratification, to identify patients with ongoing inflammation and those in whom disease activity is driven by non-inflammatory features.
No takes yet. Share an insight, caveat, or question.
Stadler et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: